Apteekin ja lääkärin yhteistyö

Peer reviewe

Community pharmacists' knowledge of COPD, and practices and perceptions of medication counseling of COPD patients

Background and purpose: COPD is one of the leading causes of morbidity and mortality worldwide. Although medication counseling interventions by pharmacists have been found to support the management of COPD, little is known about pharmacists' knowledge concerning COPD and regular practices and perceptions concerning medication counseling of COPD patients. The purpose of this study was to research these topics among Finnish community pharmacists. Materials and methods: In January 2017, an electronic survey was e-mailed to Finnish community pharmacies (n=741) via the Association of the Finnish Pharmacies. One pharmacist from each pharmacy, preferably a specialist in asthma, was invited to answer the survey. Results: Completed responses were received from 263 pharmacists (response rate =35%), of whom 196 pharmacists were specialists in asthma. Response rate among asthma pharmacists was 42%. Pharmacists were positive about their role in medication counseling and in support of the self-management of COPD patients. COPD-related knowledge was self-assessed as being good and was on a good level in respect of basic facts. However, almost half (46%) of the pharmacists did not know that COPD is considered a national public health issue, and similar to 50% of the pharmacists were not familiar with the current care guideline on COPD. Medication counseling was found to be more medicinal product-driven and less advisory concerning lifestyle changes such as smoking cessation and physical exercise. Conclusion: Although the pharmacists' knowledge of COPD was good on general topics, there were some gaps in their knowledge on the current care guideline and status of the disease. Pharmacists should more systematically individually target medication counseling according to patients' needs. In addition, lifestyle treatments, including smoking cessation and physical exercise, should be part of the medication counseling.Peer reviewe

Is pharmacy personnel a significant source of information for patients with asthma?

Suomenkielinen tiivistelmäPeer reviewe

Are there differences in the treatment information received to support guided self-management between asthma and allergy patients?: A community pharmacy survey in Finland

Peer reviewe

Allergic multimorbidity is associated with self-reported anaphylaxis in adults-A cross-sectional questionnaire study

Background Anaphylaxis has increased over the last two decades in Europe, reaching an estimated prevalence of 0.3% and an incidence of 1.5-7.9 per 100,000 person-years. Allergic multimorbidity is associated with asthma severity, yet its role in anaphylaxis is not fully understood. Our aim was to study association between allergic multimorbidity and anaphylaxis in adults. Methods We used population-based data from the Finnish Allergy Barometer Study (n = 2070, age range: 5-75). Food allergy (FA), atopic dermatitis (AD), allergic rhinitis (AR) and allergic conjunctivitis (AC), were defined from a self-completed questionnaire. A logistic regression adjusted on potential confounders (sex, age, smoking status) was applied to estimate the anaphylaxis risk associated with allergic multimorbidity. Results 1319 adults with at least one allergic disease (FA, AD, AR, AC) with/without asthma (AS) were included. Of these, 164 had self-reported anaphylaxis [mean (SD, min-max) 54 (14, 22-75) years, 17% men]. AS, FA, AR, AC, or AD were reported by 86.0%, 62.2%, 82.3%, 43.3%, and 53.7% of subjects with anaphylaxis and respectively by 67.8%, 29.5%, 86.2%, 29.4%, and 34.4% of subjects without anaphylaxis. Compared with subjects exhibiting only one allergic disease, the risk of anaphylaxis increased with the number of allergic diseases; adjusted odds ratios (OR) [CI95%] for two, three, four and five coinciding allergic diseases were 1.80 [0.79-4.12], 3.35 [1.47-7.66], 7.50 [3.25-17.32], and 13.5 [5.12-33.09], respectively. The highest risk of anaphylaxis (6.47 [4.33-9.92]) was associated with FA + AS or their various variations with AR/AC/AD embodied, when compared with AR, AC, and AS separately or their combinations. Conclusions Anaphylaxis was positively associated with the number of allergic diseases a subject exhibited and with subgroups including FA and/or AS. The results can be applied when estimating the risk of anaphylaxis for individual patients.Peer reviewe

Lääkärien ja apteekkien yhteistyötä kannattaa kehittää

Voisiko reseptin ”Viesti lääkärille”-kenttää hyödyntää paremmin? Tai voisiko apteekki muistuttaa asiakkaitaan pitkäaikaissairauden kontrollista? Apteekkien ja muun terveydenhuollon yhteistyöhön kehitettyjä malleja on nyt kerätty yhteen. Niistä voi saada ideoita omaankin työhö

Astma ja allergia lievenevät Suomessa - apteekkien allergiabarometri 2010-2016

Teema : Astman tutkimukset ja hoidotLähtökohdat Apteekeissa on seurattu barometrikyselyillä astma- tai allergialääkkeitä ostavien potilaiden oireita sekä lääkkeiden ja terveydenhuollon käyttöä. Menetelmät Kyselyyn osallistui 956 ostajaa vuonna 2016 ja 1 114 vuonna 2010; Vastaajista 60 %:lla ja 59 %:lla oli oikeus erityiskorvaukseen pysyvästä astmalääkityksestä. Vertasimme heidän ilmoittamaansa oireiden vaikeutta. Tulokset Vuonna 2016 vastaajista 2,5 % arvioi astmansa vaikeaksi, vuonna 2010 luku oli 3,8 %. Vaikeita allergiaoireita, hengenahdistusta ja hengityksen vinkumista oli merkitsevästi vähemmän vuonna 2016. Lähes joka yö astmaoireisiin heränneiden määrä väheni 15 %:sta 8 %:iin. Päivystyskäyntejä astman vuoksi oli vuoden aikana 16 %:lla ja sairaalahoitoja 6 %:lla vuonna 2016 vastanneista. Päätelmät Astmaa sairastavien vointi on Suomessa parantunut ja vain pienellä osalla tauti on vaikea. ¬Kansallisen allergiaohjelman aikana 2010–16 oireilu on edelleen hieman lieventynyt. Päivystyskäyntejä ja sairaalahoidon tarvetta voidaan vielä vähentää.Peer reviewe

ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice

Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis. It strengthens the ARIA change management strategy in the prevention and management of airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed